|
Symbol Name ID |
Epm2a
epilepsy, progressive myoclonic epilepsy, type 2 gene alpha MGI:1341085 |
Excel File
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Epm2aTg(TcraK,TcrbK)TG-BFlv/Epm2a+ involves: C57BL/6 * C57BL/10 * C57BR/cd * CBA/J |
abnormal DNA methylation | J:112696 |
| increased T cell derived lymphoma incidence | J:112696 | |
| premature death | J:112696 | |
| Epm2aTg(TcraK,TcrbK)TG-BFlv/Epm2a+ involves: C57BL/6J * CBA/J |
increased CD8-positive, alpha-beta T cell number | J:107545 |
| Epm2aTg(TcraK,TcrbK)TG-BFlv/Epm2a+ Tg(Ela1-TAg)18Bri/0 involves: C57BL/6 * CBA/J * SJL |
abnormal exocrine pancreas morphology | J:107545 |
| abnormal pancreas morphology | J:107545 | |
| pancreas inflammation | J:107545 | |
| Epm2atm1Kzy/Epm2atm1Kzy Ppp1r3ctm1Adpr/Ppp1r3ctm1Adpr involves: 129P2/OlaHsd * C57BL/6J |
abnormal Purkinje cell morphology | J:242756 |
| normal homeostasis/metabolism phenotype | J:242756 | |
| Lafora bodies | J:242756 | |
| normal nervous system phenotype | J:242756 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/09/2024 MGI 6.23 |
|
|
|
||
Analysis Tools